JP2014062109A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014062109A5 JP2014062109A5 JP2013246532A JP2013246532A JP2014062109A5 JP 2014062109 A5 JP2014062109 A5 JP 2014062109A5 JP 2013246532 A JP2013246532 A JP 2013246532A JP 2013246532 A JP2013246532 A JP 2013246532A JP 2014062109 A5 JP2014062109 A5 JP 2014062109A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- weight
- use according
- salts
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 5
- 229940079593 drug Drugs 0.000 claims 4
- 239000002537 cosmetic Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- -1 4-alkylresorcinol Chemical compound 0.000 claims 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims 2
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims 2
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims 2
- 229920002079 Ellagic acid Polymers 0.000 claims 2
- 229940119217 chamomile extract Drugs 0.000 claims 2
- 235000020221 chamomile extract Nutrition 0.000 claims 2
- 235000017471 coenzyme Q10 Nutrition 0.000 claims 2
- 229960002852 ellagic acid Drugs 0.000 claims 2
- 235000004132 ellagic acid Nutrition 0.000 claims 2
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 claims 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims 2
- 229960000401 tranexamic acid Drugs 0.000 claims 2
- 229940035936 ubiquinone Drugs 0.000 claims 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims 1
- 229950006790 adenosine phosphate Drugs 0.000 claims 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000019612 pigmentation Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000001655 ubiquinone group Chemical group 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013246532A JP5766258B2 (ja) | 2004-09-22 | 2013-11-28 | 色素沈着予防又は改善剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004274454 | 2004-09-22 | ||
| JP2004274454 | 2004-09-22 | ||
| JP2004376562 | 2004-12-27 | ||
| JP2004376562 | 2004-12-27 | ||
| JP2013246532A JP5766258B2 (ja) | 2004-09-22 | 2013-11-28 | 色素沈着予防又は改善剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012144388A Division JP5514268B2 (ja) | 2004-09-22 | 2012-06-27 | 色素沈着予防又は改善剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014062109A JP2014062109A (ja) | 2014-04-10 |
| JP2014062109A5 true JP2014062109A5 (enrdf_load_stackoverflow) | 2014-05-22 |
| JP5766258B2 JP5766258B2 (ja) | 2015-08-19 |
Family
ID=47011852
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012144388A Expired - Lifetime JP5514268B2 (ja) | 2004-09-22 | 2012-06-27 | 色素沈着予防又は改善剤 |
| JP2013246532A Expired - Lifetime JP5766258B2 (ja) | 2004-09-22 | 2013-11-28 | 色素沈着予防又は改善剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012144388A Expired - Lifetime JP5514268B2 (ja) | 2004-09-22 | 2012-06-27 | 色素沈着予防又は改善剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP5514268B2 (enrdf_load_stackoverflow) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5514268B2 (ja) * | 2004-09-22 | 2014-06-04 | 大塚製薬株式会社 | 色素沈着予防又は改善剤 |
| JP6430109B2 (ja) * | 2012-11-02 | 2018-11-28 | ロート製薬株式会社 | 外用組成物 |
| JP6057697B2 (ja) * | 2012-12-25 | 2017-01-11 | 株式会社マンダム | 皮膚用乳化組成物 |
| JP6166544B2 (ja) * | 2013-02-13 | 2017-07-19 | 第一三共ヘルスケア株式会社 | 色素沈着症の予防又は治療剤 |
| JP6180816B2 (ja) * | 2013-06-24 | 2017-08-16 | ポーラ化成工業株式会社 | 皮膚外用剤 |
| AU2019214050A1 (en) * | 2018-01-31 | 2020-08-27 | Otsuka Pharmaceutical Co., Ltd. | Method for suppressing discoloration of external composition containing adenosine phosphate and tranexamic acid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5514268B2 (ja) * | 2004-09-22 | 2014-06-04 | 大塚製薬株式会社 | 色素沈着予防又は改善剤 |
| JP5093998B2 (ja) * | 2004-09-22 | 2012-12-12 | 大塚製薬株式会社 | 色素沈着予防又は改善剤 |
-
2012
- 2012-06-27 JP JP2012144388A patent/JP5514268B2/ja not_active Expired - Lifetime
-
2013
- 2013-11-28 JP JP2013246532A patent/JP5766258B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014062109A5 (enrdf_load_stackoverflow) | ||
| CA2894891A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| EP2833721A4 (en) | NICKEL OXIDE RELEASING PHARMACEUTICAL COMPOSITIONS | |
| BR112015014372A2 (pt) | inibidores de autotaxina | |
| CA2894892A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| HUE061596T2 (hu) | Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben | |
| BR112014014262A2 (pt) | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. | |
| IL235020A0 (en) | History of n-phenylbenzenesulfonamide, pharmaceutical preparations containing them and their use in the preparation of medicines | |
| HUE053113T2 (hu) | Bardoxolon-metil 2,2-difluorpropionamid-származéka, annak gyógyszerkészítményei és polimorfjai bizonyos betegségek kezelésében történõ alkalmazásra | |
| JP2015078230A5 (enrdf_load_stackoverflow) | ||
| CL2016002132A1 (es) | Uso de una cantidad de laquinimod, que sirve para preparar un medicamento para tratar un paciente humano afectado con esclerosis múltiple o que presenta un síndrome clínicamente aislado; un paquete, una cantidad de laquinimod y una composición farmacéutica del mismo. | |
| CL2014002757A1 (es) | Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer. | |
| JP2013014622A5 (enrdf_load_stackoverflow) | ||
| BR112015017251A8 (pt) | composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas | |
| JP2015525757A5 (enrdf_load_stackoverflow) | ||
| HRP20191523T1 (hr) | Paraziticidne kombinacije spirocikličkog izoksazolina | |
| IL232764A (en) | Fluoromethyl6,5 - Dihydro - 4 H - [3,1] Oxazines, Pharmaceuticals Containing Them and Their Use in the Preparation of Medicines to Treat Alzheimer's Disease | |
| BR112015001207A8 (pt) | derivados de carbamato/ureia, seus usos, composição farmacêutica, forma livre e seu método de preparação | |
| EP2830698A4 (en) | NITROGEN OXIDE RELEASE DEVICES | |
| RU2017141536A (ru) | Замещенные производные индол-5-ола и их терапевтические применения | |
| WO2016040814A3 (en) | Disulfide polymers and methods of use | |
| JP2016538288A5 (enrdf_load_stackoverflow) | ||
| JP2011157392A5 (enrdf_load_stackoverflow) | ||
| JP2017517574A5 (enrdf_load_stackoverflow) | ||
| WO2015011653A9 (en) | pH RESPONSIVE ORAL POLYMERIC PHARMACEUTICAL DOSAGE FORM |